U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07345143) titled 'Artificial Intelligence and Gestacional Diabetes' on Nov. 13, 2025.
Brief Summary: Artificial intelligence (AI) technology can assist medical teams in remote monitoring and continuing education of women with gestational diabetes (GDM), potentially improving adherence to interventions and impacting outcomes. An AI remote monitoring model called "monitoring model for women with GDM using pharmacological therapy," created by the ChamouDr technical team, will be analyzed focusing on disease education, glycemic control monitoring, and therapeutic interventions. Women diagnosed with GDM are invited to participate in the study and sign a f...